Sysmex Corporation Appoints John Kershaw as Deputy in Charge of Divisions of Business Strategy Development, Hematology/Urinalysis, Immunochemistry/Clinical Chemistry/Hemostasis and Engineering, Effective April 3, 2017
March 29, 2017 at 09:00 am EDT
Share
Sysmex America Inc. (SAI) announced multiple leadership moves to further the company's growth and prominence throughout North and South America. All changes will be effective April 3, 2017. John Kershaw, currently chairman of the board, chief executive officer and president of SAI, will accept a greater role in Sysmex Corporation at its headquarters in Kobe, Japan. Kershaw will be deputy in charge of the divisions of business strategy development, hematology/urinalysis, immunochemistry/clinical chemistry/hemostasis and engineering. Kershaw will retain the title of chairman of SAI. Kershaw was a founding member of Sysmex U.K. Limited in 1991, came to SAI in 1999 and has been CEO since 2009.
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Sysmex Corporation Appoints John Kershaw as Deputy in Charge of Divisions of Business Strategy Development, Hematology/Urinalysis, Immunochemistry/Clinical Chemistry/Hemostasis and Engineering, Effective April 3, 2017
SYSMEX CORPORATION 
